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Fully-grown G2-arrested Xenopus oocytes resume meiosis upon hormonal stimulation. Resumption of meiosis is characterized by
germinal vesicle breakdown, chromosome condensation, and organization of a bipolar spindle. These cytological events are accompanied by
activation of MPF and the p39Mos–MEK1–Xp42Mpk1–p90Rsk pathways. The latter cascade is activated upon p39Mos accumulation. Using
U0126, a MEK1 inhibitor, and p39Mos antisense morpholino and phosphorothioate oligonucleotides, we have investigated the role of the
members of the p39Mos–MEK1–Xp42Mpk1–p90Rsk in spindle morphogenesis. First, we have observed at a molecular level that prevention
of p39Mos accumulation always led to MEK1 phosphorylation defects, even when meiosis was stimulated through the insulin Ras-dependent
pathway. Moreover, we have observed that Raf1 phosphorylation that occurs during meiosis resumption was dependent upon the activity of
MEK1 or Xp42Mpk1 but not p90Rsk. Second, inhibition of either p39Mos accumulation or MEK1 inhibition led to the formation of a
cytoplasmic aster-like structure that was associated with condensed chromosomes. Spindle morphogenesis rescue experiments using
constitutively active Rsk and purified murine Mos protein suggested that p39Mos or p90Rsk alone failed to promote meiotic spindle
organization. Our results indicate that activation of the p39Mos–MEK1–Xp42Mpk1–p90Rsk pathway is required for bipolar organization of
the meiotic spindle at the cortex.
D 2005 Elsevier Inc. All rights reserved.Keywords: Spindle formation; p39Mos; MAP Kinase; Meiosis; XenopusIntroduction
Fully-grown Xenopus laevis oocytes are arrested at
prophase of the first meiotic division. In response to
stimulation by steroid hormones, they resume meiosis in a
process called maturation. Release from prophase I-arrest is
analogous to G2/M transition, and is characterized by the
movement of the nucleus or germinal vesicle (GV) towards
the animal cortex, breakdown of the nuclear envelope0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.04.031
* Corresponding author. Fax: +33 32043 4038.
E-mail address: Jean-Francois.bodart@univ-lille1.fr (J.-F.L. Bodart).
1 Co-authors.(germinal vesicle breakdown or GVBD), chromosome
condensation, and the formation of a bipolar spindle.
Anchoring of the spindle at the cortex is accompanied by
the appearance of a white spot (WS) at the apex of the
oocyte. The first meiotic division is completed after extru-
sion of the first polar body. The second division resumes in
absence of interphase and arrests at metaphase II in
preparation for fertilization (Hausen and Riebesell, 1991).
The molecular mechanisms underlying the morphogen-
esis of the first meiotic spindle are poorly characterized.
Unlike mitosis, first meiotic spindle formation in Xenopus
oocytes proceeds in absence of active centrosomes. Indeed,
centrosomes are functionally inactivated at earlier stages of
oogenesis (Gard et al., 1995).283 (2005) 373 – 383
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the activation of protein kinase signaling pathways culmi-
nating with the activation of M-phase promoting factor
(MPF), a cytoplasmic protein complex that controls G2/M
transition. MPF is a heterodimer made up of two subunits: a
catalytic subunit, the kinase p34Cdc2/Cdk1, and a regulatory
subunit, the cyclin B (for review, see Masui, 2001; Nurse et
al., 1998). At the same time, Xp42Mpk1 is phosphorylated
and activated (Ferrell et al., 1991). Xp42Mpk1 is a mitogen-
activated protein kinase (MAPK) that is turned on following
progesterone-induced synthesis of p39Mos (a mitogen-
activated protein kinase kinase kinase) and subsequent
phosphorylation of mitogen-activated protein kinase kinase
1 (MEK1) (Nebreda and Hunt, 1993; Sagata et al., 1988).
Xp42Mpk1 in turn phosphorylates and activates ribosomal S6
kinase (p90Rsk). Accumulation of p39Mos can either be
controlled by Xp42Mpk1 through the regulation of p39Mos
mRNA translation (Howard et al., 1999) or by MPF-
dependent mechanisms (Frank-Vaillant et al., 1999). Activ-
ity of the p39Mos–Xp42Mpk1 pathway is not required in
Xenopus oocytes (Bodart et al., 2002; Fisher et al., 1999;
Gross et al., 2000). However, this pathway has been shown
to be responsible for S-Phase suppression between meiosis I
and meiosis II; inhibition of p39Mos synthesis (Dupre et al.,
2002; Furuno et al., 1994) or inhibition of MEK1 activity
(Gross et al., 2000) prevents meiosis I–meiosis II transition
and allows inappropriate DNA replication.
Available evidence indicates that the MAPK pathway is
involved in spindle formation and stabilization. In mouse
oocytes, MAPK has been found to be associated with
MTOC (Verlhac et al., 1994). In mouse and pig oocytes,
MAPK distributes to the metaphase spindle and migrates to
the middle of the spindle during the transition from
anaphase to telophase (Hatch and Capco, 2001; Lee et al.,
2000). The same pattern of distribution has been observed
for its downstream effector, p90Rsk (Fan et al., 2003).
Interestingly, amphibian and mammalian oocytes in which
the MAPK pathway is inactive fail to assemble a normal
spindle (Araki et al., 1996; Bodart et al., 2002; Choi et al.,
1996; Zhao et al., 1991). Phosphorylation of two MAP
kinase substrates is required for normal meiotic spindle
morphogenesis in mouse oocytes (Lefebvre et al., 2002;
Terret et al., 2003). However, mouse oocytes deficient in
MAP kinase activity can still divide and release polar body.
In this case, the polar body is abnormally large (Verlhac
et al., 2000).
This study was undertaken to analyze in vivo the effects
of p39Mos–Xp42Mpk1 pathway on meiotic spindle. Both
chemical inhibitor and antisense strategies were used and
their effects on the MAP kinase cascade regulation as well
as on the MEK kinase Raf1 have been analyzed and
discussed. Our results provide evidences that p39Mos is the
only MAPKK kinase involved in MEK1 phosphorylation
and that Raf complete phosphorylation is dependent upon
phosphorylation by either MEK1 or Xp42Mpk1. While
inactivation of MAP kinase leads to formation of aster-likestructures, we observed that members of p39Mos–Xp42Mpk1
pathway might play complementary but different roles in
spindle formation.Materials and methods
Isolation of oocytes
Adult Xenopus females were purchased from University
of Rennes I, France. After anesthetizing frogs by immersion
in 1 g/l MS222 solution (tricaine methane sulfonate,
Sandoz), ovarian lobes were surgically removed and placed
in ND96 medium [96 mM NaCl, 2 mM KCl, 1.8 mM
CaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.5 (NaOH)].
Fully-grown stage VI oocytes (Dumont, 1972) were isolated
and defolliculated by partial collagenase treatment for
30 min (1 mg/ml collagenase A, Roche), followed by
manual microdissection. Oocytes were stored at 14-C in
ND96 medium prior to use. All treatments were started
within 24 h of ovarectomies.
Antisense oligonucleotides
Phosphorothioate deoxyribo-oligonucleotides were pur-
chased from Eurogentec. The sequence of the antisense
against p39Mos was AAGGCATTGCTGTGTGACTCGCT-
GAAAC and was similar to those described in Sagata et al.
(1988). As control, we used the inverted sequence GTTTC-
AGCGAGTCACACAGCAATGCCTT designed as sense
oligonucleotides or RNase free water.
Morpholino oligonucleotides were purchased from Gene
Tools. The sequence of the antisense against p39Mos was
GGGAAGGCATTGCTGTGTGACTCGC. As a control, we
used the inverted sequence CGCTCAGTGTGTCGTTACG-
GAAGGG and also a standard sense control CCTCTTACC-
TCAGTTACAATTTATA.
For both phosphorothioate and morpholino oligonucleo-
tides, 1 ng was microinjected into each oocyte by the use of
a positive displacement digital micropipette (Nichiryo).
Oocytes were then incubated in ND96 medium for
progesterone experiments and in OR-2 medium for insulin
experiments (see Baert et al., 2003). U0126 (Promega) was
prepared in DMSO and used at a final concentration of 10 to
50 AM. Treatments began 1 h before progesterone or insulin
addition. Control oocytes were treated with an identical
amount of DMSO (0.2 to 1).
Oocyte treatments
Purified murine Mos protein (Mu-Mos) was kindly
provided by Dr. Vande Woude. Purified constitutively active
Rsk (CA-Rsk) was a gift of Dr. Nebreda (Perdiguero et al.,
2003). Mu-Mos (37.5 ng) and CA-Rsk (5 ng) were injected
into each oocytes (in a volume of 50 nl) just prior to
progesterone or insulin treatment.
Fig. 1. Dose-dependent effects of MEK inhibitor U0126 on progesterone-
induced GVBD. (A) Control oocytes were incubated in ND medium
containing 1/1000 DMSO (open circles). U0126-inhibited oocytes were
incubated in ND medium containing 10 (black circle), 25 (open square), or
50 AM U0126 (black square). 1 h after U0126 addition, oocytes were
stimulated with progesterone. White spots were scored every hour and
GVBD was assessed by dissection of oocytes. (B) Western blot analysis. At
the end of treatment (20 h), 5 oocytes were taken off, homogenized and
immunoblotted with antibodies against p39Mos, Xp42Mpk1, phospho-MEK,
and p90Rsk.
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oocytes in ND96 medium containing 10 AM progesterone
(Sigma). Incubation in DMSO (1) or injection with PSS
(Phosphorothioate Sense oligonucleotide) was used as con-
trols for U0126 and PSAS (Phosphorothioate Antisense
oligonucleotide) experiments, respectively. Batches of
injected oocytes (30 to 60) from different females (n =number
of animals) were observed every hour and scored for the
appearance of white spot. Experiments were ended 2 h after
stabilization of white-spot percentage (10 to 14 h after first
white-spot appearance). Three to 5 oocytes were frozen at
20-C for later biochemical analysis and the rest of the
oocytes were fixed for cytological analysis (see below).
Cytological and immunocytological analysis
For classical cytological analysis, oocytes were fixed
overnight in Smith’s fixative, dehydrated, and embedded in
paraffin. Sections (7 Am thick) were stained with nuclear red
to detect nuclei and chromosomes and with picroindigo
carmine that reveals cytoplasmic structures.
For immunocytological analysis, oocytes were fixed
overnight in cold methanol, which was gradually replaced
by butanol before embedding in paraffin. 10-Am sections
were cut and stained with 1 Ag/ml Hoechst 33342 (Sigma)
to visualize chromosomes. Microtubules were stained with
monoclonal anti-tubulin antibody Tub 2.1 (Sigma). Primary
antibodies were revealed with antimouse antibody coupled
to Oregon Green (Molecular Probes).
Western blotting
Oocytes were lysed in homogenization buffer (Azzi et al.,
1994) and then centrifuged for 5 min at 10,000g (4-C) to
eliminate yolk platelets. Proteins were then separated on a
12.5% mini-SDS-polyacrylamide gel for phospho-MEK
immunodetection or on a modified 17.5% polyacrylamide
gel for Raf, p39Mos, Xp42Mpk1, and p90Rsk immunodetection
(Bodart et al., 1999). Xp42Mpk1 was detected using the D-2
monoclonal antibody (Santa Cruz Biotechnology; 1/1000).
p39Mos was detected using the C238 polyclonal antibody
(Santa Cruz Biotechnology; 1/1000). p90Rsk detection was
performed using the C21 polyclonal antibody (Santa Cruz
Biotechnology; 1/1000). Raf was detected using the C20
polyclonal antibody (Santa Cruz Biotechnology; 1/500) and
phospho-MEK detection was performed using a polyclonal
antibody (Calbiochem; 1/1000). Signals were detected by
using enhanced chemoluminescence (Amersham).
Statistical analysis
Statistical analyses of kinetic experiments were per-
formed by a logrank test (survival test). Observed counts in
cytological studies were compared using the chi-square
analysis of contingency tables or the Fisher exact test if one
or more values were equal to zero.Results
Dose-dependent effects of MEK inhibition on G2/M
transition
To analyze the impact of the inhibition of the p39Mos–
MEK1–Xp42Mpk1–p90Rsk pathway on spindle morphogen-
esis, we determined the effects of two strategies on
Xp42Mpk1 activity and p39Mos accumulation.
Dose-dependent effects of the MEK inhibitor U0126 on
meiotic resumption induced by progesterone or insulin were
first investigated. Previous observations reported by Gross et
al. (2000) indicated that 50 AM U0126 did not block
progesterone-induced GVBD but rather delayed it. Using
increasing concentration of U0126 (10 to 50 AM) on
progesterone-stimulated oocytes, we similarly observed that
U0126 never prevented GVBD though it did delay GVBD
(Fig. 1A). Even at 100 AM, U0126 did not prevent GVBD
(data not shown). In oocytes treated by U0126 10 AM, time
of GVBD50 (time to which 50% of the oocytes underwent
J.-F.L. Bodart et al. / Developmental Biology 283 (2005) 373–383376meiotic resumption) was 1.5 T 0.2 fold of GVBD50 of control
oocytes treated with DMSO. By contrast, in oocytes treated
with U0126 50 AM, time of GVBD50 was 1.8 T 0.1 fold of
control oocytes. This difference may suggest that the effects
of U0126 may be dose-dependent. In support of this, a
logrank test showed heterogeneity between GVBD kinetics
in DMSO, U0126 10, 20, and 50 AM (P < 0.05, n = 4).
The preceding results suggest that MAPK activity is
dispensable for GVBD in Xenopus oocytes. To confirm this,
we examined the effects of U0126 upon p39Mos accumula-
tion as well as the phosphorylation status of Xp42Mpk1 and
its downstream target p90Rsk by Western blotting at the end
of each experiment (20 h post-progesterone; Fig. 1B). In
immature oocytes (Fig 1B, first lane) p39Mos was not
detectable and Xp42Mpk1 and p90Rsk were unphosphory-
lated. In control oocytes treated with DMSO and stimulated
with progesterone (second lane), p39Mos was present and
Xp42Mpk1 and p90Rsk were phosphorylated. By contrast,
Xp42Mpk1 and p90Rsk phosphorylation were only partially
inhibited in oocytes treated with 10 AM U0126 and
progesterone, whereas they were totally inhibited in U0126
25-AM- and 50-AM-treated oocytes. However, U0126
treatment up to 50 AM never abolished p39Mos accumulation
but resulted in a slight decrease of the detected amounts
(Fig. 1B). Phosphorylation of MEK1 was never inhibited
even if concentration of U0126 was increased up to 50 AM.
This observation agrees with report of Davies et al. (2000),
which demonstrated that U0126 blocks Xp42Mpk1 phos-
phorylation through direct inhibition of phosphorylated
MEK1 and not by preventing phosphorylation of MEK1.
As we already showed in insulin-treated oocytes (Baert et
al., 2003), U0126 incubation partially inhibited Raf phos-
phorylation in progesterone-stimulated oocytes (Fig. 5, lane
7). These results show that MAPK activity is indeed
dispensable for GVBD in Xenopus oocytes.
Interestingly, though inhibition of MAPK activation did
not prevent GVBD, it did significantly inhibit white-spot
formation. The percentage of control (DMSO-treated)
oocytes with white spots was 93.1% T 3.6 compared with
66% T 9.8, 58.7% T 9.1, and 58.1% T 8.8 of oocytes treated
with 10, 25, or 50 AMU0126, respectively. Decreased white-
spot formation was not a reflection of delayed progression
through meiosis as the rate of white-spot formation in
U0126-treated oocytes did not increase beyond these levels
for at least 20 h after progesterone treatment. These results
suggest that inhibition of MAPK activation somehow
interferes with anchoring of the meiotic spindle at the cortex.
Effects of p39Mos morpholinos antisense on G2/M transition
induced by hormonal stimulation
The effects of U0126 upon GVBD may be attributed to
non-specific effects on different signaling pathways. To
control for this, we used alternative strategies to inhibit the
p39Mos–Xp42Mpk1 pathway. Previously, we have reported
that injection of antisense phosphorothioate oligonucleo-tides of p39Mos (p39Mos PSAS) not only prevented
activation of the p39Mos–Xp42Mpk1 pathway but also
delayed GVBD (Baert et al., 2003). Here, we report similar
effects with antisense Morpholino oligonucleotides (p39Mos -
MAS) against p39Mos synthesis on progesterone-stimulated
oocytes (Fig. 2A). Injection of 1 ng of sense Morpholinos
oligonucleotides (p39Mos-MS) of p39Mos had no effect on
maturation time course: time of GVBD50 was 1.0 T 0.1
fold those of control oocytes injected with water. In
contrast, the time of GVBD50 of p39
Mos-MAS-injected
oocytes was increased by 1.4 T 0.1 fold.
To confirm that these oligonucleotides prevented p39Mos
synthesis, we used Western blotting to examine their effects
on the p39Mos–Xp42Mpk1 pathway (Fig. 2B). p39Mos was
detected in neither immature oocytes nor p39Mos-MAS-
injected oocytes. As expected, lack of p39Mos synthesis
resulted in abolition of Xp42Mpk1 and p90Rsk activation as
demonstrated by their lack of phosphorylation (Fig. 2B).
Our results showed that, like p39Mos-PSAS, p39Mos-MAS
prevents p39Mos synthesis, MEK1 phosphorylation, and
Xp42Mpk1 activation (Fig. 2B) and causes a delay in GVBD.
Thus, both phosphorothioate and Morpholinos strategies
can be used as alternative strategies to prevent activation of
the p39Mos–Xp42Mpk1 pathway.
Blocking p39Mos synthesis or inhibition of MEK1 alters
bipolar spindle morphogenesis and induces aster-like
formation following progesterone stimulation
Our observation that white-spot formation was inhib-
ited by U0126 suggested that MAPK inhibition interfered
with meiotic spindle anchoring at the cortex. Curiously,
p39Mos-MAS injection had little or no effect on white-spot
formation (Fig. 2A). In progesterone-stimulated oocytes,
p39Mos-MAS injection resulted in 82.0% T 7.3 of white spot
compared to 85.5% T 3.3 in water-injected oocytes and
75.6% T 8.6 in p39Mos-MS-injected oocytes. To investigate
this further, we performed cytological and immunocytologi-
cal analyses on progesterone and insulin-stimulated oocytes
that had been treated with either U0126 or p39Mos-antisense
oligonucleotides. These analyses were performed 2 h after
stabilization of white-spot percentage. Control DMSO-
treated oocytes stimulated by progesterone exhibited meiotic
spindles at the cortex with condensed chromosomes on a
metaphase plate in 93.0% T 5.0 of oocytes examined (Table 1;
Figs. 3F–H) and spindle formation was slightly decreased in
control oocytes injected with p39Mos-PSS (82.0% T 1.1
bipolar spindle; Table 1 and Figs. 3L–N). Similarly, although
the proportion of oocytes with bipolar spindles were lower in
control p39Mos-MS-injected oocytes, there was no significant
difference in regard to cytological structures found in p39Mos-
MS-injected versus control H2O-injected oocytes (58.0 T
7.1and 73.2 T 5.7%, respectively; Table 1). Similarly, there
was no significant difference between H2O and p39
Mos-PSS-
injected oocytes (n = 5). By contrast, inhibition of the
p39Mos–Xp42Mpk1 pathway using antisense oligonucleotides
Fig. 2. p39Mos accumulation, MEK1 phosphorylation, Xp42Mpk1 and p90Rsk activation, and Raf full phosphorylation are prevented by p39Mos antisense
oligonucleotides in progesterone-stimulated oocytes. (A) Control oocytes were micro-injected with water (H2O/pg; open circles) or p39
Mos-sense Morpholinos
oligonucleotides (MS/pg; black circles). A batch of oocytes was micro-injected with p39Mos-antisense Morpholinos oligonucleotides (MAS/pg; open squares).
Murine Mos (Mu-Mos) has also been injected in MAS-injected oocytes (MAS/Mu-Mos/pg; black squares). After overnight incubation, oocytes were stimulated
by progesterone. Appearance of white spot was monitored every 30 min and GVBD was assessed by dissection of oocytes. (B) Western blot analysis was
performed either on Morpholinos and Phosphorothioate Oligonucleotide-injected oocytes. At the end of treatment (16 h), 5 oocytes were taken off,
homogenized and immunoblotted with antibodies against p39Mos, phospho-MEK, Xp42Mpk1, p90Rsk, and Raf. Murine Mos (Mu-Mos) injection restored Raf
and MEK1 phosphorylation but did only partially restore Xp42Mpk1 and p90Rsk levels of phosphorylation.
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formation (Table 1; Figs. 3R, S and 4J, K). Bipolar meiotic
metaphase spindles were observed in only 17.0% T 7.2 of the
oocytes treated with 50 AM U0126, in 10.0% T 10.0 of
oocytes injected with p39Mos-PSAS and in 3.8% T 3.8 of
oocytes injected with p39Mos-MAS (Table 1). Statistical
analysis confirmed that there was a significant difference
between DMSO and U0126 50 AM-treated oocytes, between
p39Mos-MS and p39Mos-MAS-injected oocytes and between
p39Mos-PSS and p39Mos-PSAS-injected oocytes (each P <
0.001, n = 3).
The percentage of bipolar spindles observed in U0126-
treated oocytes decreased in a dose-dependent manner
(Table 1; Fig. 3R): whereas 41.0% T 19.5 of 10 AM
U0126-treated oocytes exhibited a bipolar spindle, only9.2% T 5.8 of 25 AM U0126-treated oocytes did (Table 1;
Fig. 3R). If we failed to detect bipolar spindles in these
oocytes, we observed aster-like structures (Table 1; Fig.
3R). The formation of aster-like structures in U0126-treated
oocytes appeared to be dose-dependent (Table 1; Fig 3R);
10 AM U0126 induced aster formation in 17.9% T 17.9 of
oocytes whereas 50 AM U0126 led to the formation of aster-
like structures in 61.2 T 9.3 of oocytes (P <0.05).
Similar to U0126-treated oocytes, aster-like structures
were found in 76.0% T 10.8 of the oocytes injected with
p39Mos-PSAS (Table 1; Figs. 3O–Q and 4K) and 78.7% T
2.9 of the oocytes injected with p39Mos-MAS (Table 1; Figs.
3E and 4B, K). In comparison, aster-like structures were
detected only in 1.8% T 1.8 of the control oocytes treated
with 0.1% DMSO, in 14% T 3.6 of oocytes injected with
Table 1
Effects of U0126, p39Mos-MAS, and PSAS oligonucleotides on spindle
morphogenesis following progesterone-induced maturation
Treatment Number of
oocytes
(number
of females)
Metaphase
spindle
Aster No
structure
DMSO/pg 56 (3) 52 1 3
U0126 10 AM/pg 28 (3) 12 7 9
U0126 25 AM/pg 23 (3) 2 6 15
U0126 50 AM/pg 54 (7) 9 31 14
U0126 50 AM/Mu-Mos/pg 18 (2) 2 10 6
U0126 50 AM/CA-Rsk/pg 33 (3) 23 5 5
H2O/pg 34 (3) 25 2 7
MS /pg 33 (5) 18 5 10
MAS/pg 36 (4) 2 30 4
MAS/Mu-Mos/pg 73 (5) 46 16 11
PSS/pg 53 (5) 46 7 0
PSAS/pg 40 (5) 3 31 6
PSAS/Mu-Mos/pg 25 (2) 18 4 3
PSAS/CA-Rsk/pg 35 (3) 6 10 19
This table includes bipolar spindle morphogenesis rescue experiments by
Mu-Mos, CA-Rsk injection in absence of MAP kinase pathway activation
(pg: progesterone; MS: p39Mos-sense morpholino oligonucleotides; MAS:
p39Mos-antisense morpholino oligonucleotides; PSS: p39Mos-sense phos-
phorothioate oligonucleotides; PSAS: p39Mos-antisense phosphorothioate
oligonucleotides).
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p39Mos-MS (Table 1).
Upon further confirmation of these results, we noted that
the extrusion of the first polar body was also impaired by
inhibition of the p39Mos–Xp42Mpk1 pathway. Detection of
the polar body can be accurately performed on 7 Am sections:
polar bodies have distinctive shape from remaining follicular
cells and are located between the plasma membrane and the
vitelline membrane in a V-shaped depression (Figs. 3C and
4A). Though first polar bodies were found in 68.7% T 3.3 of
DMSO-incubated oocytes, they were never detected in
U0126-treated oocytes, whatever the concentration was.
While 10 AM U0126 did not totally block Xp42Mpk1 phos-
phorylation as shown in Fig. 1B, this partial inhibition was
sufficient to prevent polar body extrusion. Similarly, polar
bodies were not detected in p39Mos-MAS-injected oocytes.
To confirm the presence of condensed chromosomes in
association with these aster-like structures, we performed
immunofluorescent staining using Hoechst and antibodies
directed against tubulin on sections of cold methanol-fixed
oocytes. We observed condensed chromosomes that had
undergone diakinesis associated with microtubules both in
U0126-treated (Figs. 3I–K) and p39Mos-antisense-injected
oocytes (Figs. 3O–Q). Interestingly, where condensed
chromosomes were observed, we noted that the signal
appeared weaker than in metaphase II control oocytes. One
might argue that the aster-like structure could be interpreted
as a polar view of a misorientated metaphase spindle in the
cytoplasm. However, this is unlikely, since, on such a polar
view, we would not expect to observe nucleated micro-
tubules radiating around an aggregate of chromosomes. Theaster-like structures observed were always larger than
metaphase spindles (i.e., in 50 AM U0126-treated oocytes,
aster-shaped microtubular structures observed are 2.0 T 0.5
fold larger than control metaphase II spindle; also compare
Figs. 3H and N with K and Q) and were never located at the
cortex but rather were observed in the subcortical cyto-
plasm. Indeed, in p39Mos-PSAS-treated oocytes, microtubu-
lar structures were found at the plasma membrane in only
33.3% T 8.3 of the oocytes but in 86% T 3.6 of the cases in
p39Mos-PSS-injected oocytes. Similarly, structures were
found in subcortical area in 58.3 T 8.3 and even in deep
cytoplasm in 8.3% T 8.3 of p39Mos-PSAS-injected oocytes.
By contrast, in p39Mos-PSS-treated oocytes, structures were
observed in subcortical area in 5.5% T 5.5 of the cases and
in deep cytoplasm in 6.7% T 6.7 of the oocytes.
Collectively, these results establish that inhibition of the
p39Mos–Xp42Mpk1 pathway by either a small-molecule
inhibitor or p39Mos-antisense strategies prevents spindle
formation, not by preventing microtubule nucleation but by
blocking establishment of a bipolar axis.
CA-Rsk injection does not rescue spindle organization in
p39Mos antisense-injected oocytes
To confirm the requirement for the p39Mos–Xp42Mpk1
pathway in bipolar spindle formation, rescue experiments
were performed using Mu-Mos or CA-Rsk, a downstream
substrate of MAPK (Figs. 4 and 5). We observed that while
Mu-Mos injection rescued the establishment of a bipolar
spindle in 65.7% T 4.2 of p39Mos-MAS-injected oocytes
(n =5; Table 1; Figs. 4C and K) and in 75% of p39Mos-
PSAS-injected oocytes (n =2; Table 1 and Fig. 4K), the
injection of CA-Rsk failed to properly rescue normal
spindle morphogenesis in p39Mos-PSAS-injected oocytes
(19 T 13.2, n =3; Table 1 and Figs. 4D–F and K). We
determined that there were no significant differences
between control oocytes injected with p39Mos-PSS and
oocytes co-injected with Mu-Mos and p39Mos-PSAS, as
well as between control oocytes injected with p39Mos-MS
and oocytes co-injected with Mu-Mos and p39Mos-MAS.
Consistent with its role as an upstream activator of MEK1,
we observed thatMu-Moswas not able to restore ametaphase
spindle at the cortex in U0126-treated oocytes (12.5%
metaphase spindle vs. 57.5% aster; Table 1 and Fig. 4J).
However, CA-Rsk injection at the same concentration as was
used in antisense-injected oocytes rescued normal bipolar
spindle in 74.9% T 12.6 of U0126-treated oocytes (Table 1;
Figs. 4G–I and J). These results indicate that inhibition of
bipolar spindle formation is a specific consequence of MAP
kinase pathway inhibition.Discussion
Taken together, our results obtained using p39Mos
antisense strategies and chemical inhibitors of MEK as well
Fig. 3. Effects of U0126 or p39Mos-antisense oligonucleotides on spindle morphogenesis during progesterone-induced maturation. (A–B) Immature non-
treated oocytes. (A) Germinal vesicle (nuclear red/picro-indigocarmine staining). (B) Chromosomes decondensed at prophase I (Hoechst staining). (C)
Metaphase II-arrested oocyte exhibits typical bipolar spindle with chromosomes and the first polar body (nuclear red/picro-indigocarmine staining). (D) Typical
aster-shaped microtubular structure of a U0126-treated oocyte. (E) Typical aster-shaped microtubular structure of an antisense-injected oocyte. (F–H) Typical
bipolar spindle with chromosomes of a control oocyte treated with DMSO 1/1000 and then incubated in progesterone. Polar body remained at vitelline
membrane, which was separated from the plasma membrane because of oocyte’s sections. (F) Hoechst staining. (G) Anti-tubulin staining of the same figure as
panel F. (H) Merging of panels F and G. (I–K) Typical aster-shaped microtubular structure with chromosomes of an oocyte treated with 50 AMU0126 and then
incubated in presence of progesterone. (I) Hoechst staining. (J) Anti-tubulin staining of the same figure as panel I. (K) Merging of panels I and J. (L–N) Typical
bipolar spindle with chromosomes of a control oocyte injected with p39Mos sense oligonucleotides and then incubated in progesterone. (L) Hoechst staining.
(M) Anti-tubulin staining of the same figure as panel L. (N) Merging of panels L and M. (O–Q) Typical aster-shaped microtubular structure with chromosomes
of an oocyte treated with p39Mos antisense oligonucleotides and then incubated in presence of progesterone. (O) Hoechst staining. (P) Anti-tubulin staining of
the same figure as panel O. (Q) Merging of panels O and P. Scale bars represent 15 Am except for panel Awhere scale bar represents 250 Am. Ast.: aster-shaped
microtubular structure, Chr.: chromosomes, PB: polar body, Sp.: bipolar spindle, GV: germinal vesicle. (R) Histogram showing percentages of the different
structure types observed in oocytes treated with DMSO or with 10, 25, or 50 AM U0126 and then incubated in presence of progesterone. Error bars represent
SEM values. Significance toward DMSO/progesterone treatment is indicated. (S) Histogram showing percentages of the different structure types observed in
oocytes treated with water (H2O), p39
Mos-sense oligonucleotides (sense), or p39Mos-antisense oligonucleotides (antisense) and then incubated in presence of
progesterone. White bars show percentages of normal bipolar spindles, gray bars show percentages of aster-shaped microtubular structures and black bars show
percentages of oocytes lacking any microtubular structures. Error bars represent SEM values. Significance toward water/progesterone treatment is indicated.
N.S.: nonsignificant (P > 0.05); *significant (P < 0.05); **very significant (P < 0.01); ***highly significant (P < 0.001).
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absence of p39Mos accumulation or Xp42Mpk1 activity
(Baert et al., 2003; Bodart et al., 2002; Dupre et al., 2002;
Gross et al., 2000). In these conditions, GVBD and MPF
activation are delayed in comparison to control oocytes.However, we observed that egg cytoplasm-induced GVBD
was delayed in p39Mos-AS-injected oocytes, whereas it
was not in U0126-treated oocytes, suggesting that p39Mos
may play a role independently of Xp42Mpk1 and p90Rsk in
control of meiosis dynamic (Sellier and Bodart, personal
J.-F.L. Bodart et al. / Developmental Biology 283 (2005) 373–383380observations). This effect could be mediated by the p39Mos
capacity to directly phosphorylate Myt1 independently of
p90Rsk (Peter et al., 2002) or to promote protein synthesis
through mos response element (de Moor and Richter, 1997).
In contrast to mouse, the involvement of the MAP kinase
pathway in spindle morphogenesis in Xenopus oocytes in
vivo has not been extensively studied. Studies have shown
that in vitro MAPK inhibition leads to half spindleformation (Horne and Guadagno, 2003). In accordance with
previous reports, we failed to observe meiotic structures at
the cortex of oocytes either treated with U0126 (Bodart et
al., 2002; Gross et al., 2000) or injected with p39Mos-
antisense Morpholinos oligonucleotides (Dupre et al.,
2002). Instead, we observed the formation of an aster-like
structure in the cytoplasm in absence of MAPK activity.
Kotani and Yamashita (2002) have reported the absence of
Fig. 5. Effects of p39Mos-antisense oligonucleotides and CA-Rsk injections
in progesterone-stimulated oocytes. Western blot analysis. Homogenized
oocytes were immunodetected with antibodies against p39Mos, phospho-
MEK, Xp42Mpk1, p90Rsk, and Raf. Constitutively active Rsk (CA-Rsk)
injections did not restore the activation of any of the p39Mos–MEK1–
Xp42Mpk1 cascade nor affected Raf level of phosphorylation.
Table 2
Requirement of members of the p39Mos –Mek1–Xp42Mpk1 –p90Rsk
pathway in meiotic spindle morphogenesis in Xenopus oocytes
Treatment Mos Xp42Mpk1 Rsk Structure observed
S/DMSO Y Y Y Spindle
U0126 Y N N Aster
U0126/Mu-Mos Y N N Aster
U0126/CA-Rsk Y N Y Spindle
p39Mos-AS N N N Aster
p39Mos-AS/CA-Rsk N N Y No structure
p39Mos-AS/Mu-Mos Y Y Y Spindle
S: p39Mos-sense oligonucleotides injection; p39Mos-AS: p39Mos-antisense
oligonucleotides injection; Mu-Mos: murine Mos injection; CA-Rsk:
constitutively active Rsk injection; Y stands for active status of protein
as assessed by the phosphorylation status of the protein itself or for its
downstream target; N stands for the absence of activation or presence of the
considered protein.
Maturation is stimulated by progesterone.
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lar formation in U0126-treated Rana japonica oocytes. In
U0126-treated oocytes, they observed a partial condensation
followed by re-condensation of chromosomes together with
a dispersed pattern of microtubules. In contrast to these
observations, we have observed microtubule nucleation in
Xenopus oocytes either treated with U0126 or injected with
p39Mos-AS oligonucleotides. These asters were associated
together with chromosomes that have undergone diakinesis.
DNA replication and cell cycling in Xenopus oocytes,
observed when MAPK pathway is inhibited (Dupre et al.,
2002; Gross et al., 2000), might account for the absence of
microtubule nucleation and chromosome condensation
observed in about 20% of treated oocytes.
MAP kinase pathway is also clearly dispensable for
GVBD to occur in mouse oocytes (Abrieu et al., 2001;
Colledge et al., 1994; Hashimoto et al., 1994). In Mos-
nullizygous mice, oocytes still exhibited spindle morpho-
genesis but spindle shape was altered and such spindle did
not migrate toward the plasma membrane. This leads to an
asymmetric division together with the extrusion of anFig. 4. Rescue of bipolar spindle morphogenesis in absence of MAP kinase pathwa
observed in oocytes injected with 10 ng sense oligonucleotides and stimulated b
structure as observed in oocytes injected with 10 ng antisense oligonucleotides
incubation. (C) Bipolar spindle with chromosomes as observed in oocytes injected
overnight and then injected with constitutively active murine Mos before proge
chromosomes as observed in oocytes injected with p39Mos antisense oligonucleo
prior to progesterone treatment. (E) Hoechst staining. (F) Anti-tubulin staining o
bipolar spindle with chromosomes as observed in oocytes treated with 50 AM
progesterone stimulation. (H) Hoechst staining. (I) Anti-tubulin staining of the sa
murine Mos restored spindle formation in U0126-treated oocytes; histogram showi
stimulated with progesterone in presence of DMSO, 50 AM U0126, or 50 AM U
represent SEM values. Significance toward DMSO/progesterone treatment is indic
AS-injected oocytes: histogram showing percentages of the different struct
oligonucleotides (MS), p39Mos-antisense Morpholino oligonucleotides (MAS), p3
phosphorothioates oligo-nucleotides (PSAS) and rescue capacity of murine Mos an
antisense oligonucleotides (MAS or PSAS) and then incubated in presence of prog
show percentages of aster-shaped microtubular structures, and black bars show per
SEM values. Significance toward water injection/progesterone treatment is indi
significant ( P < 0.01); ***highly significant ( P < 0.001).abnormally large polar body (Verlhac et al., 2000).
However, polar body extrusion was neither observed in
p39Mos-AS-injected nor in U0126-treated oocytes in which
Xp42Mpk1 phosphorylation was only partially inhibited.
Absence of migration of GV content and microtubule
toward the plasma membrane, as well as yolk platelet
surroundings, may have prevented any polar body extru-
sion. Role of p39Mos in cytostatic activity (CSF), which
maintains high levels of MPF activity in metaphase II-
arrested oocytes through the prevention of cyclin B degra-
dation, is mediated by Xp42Mpk1 (Abrieu et al., 1996;
Haccard et al., 1993; Minshull et al., 1994) and p90Rsk
(Bhatt and Ferrell, 1999; Gross et al., 1999). Meiotic spindle
defects were rescued in p39Mos-antisense-injected oocytes
by the injection of Mu-Mos, indicating that the activation of
the p39Mos–MEK1–Xp42Mpk1–p90Rsk cascade was specif-
ically involved in the establishment of the bipolar axis of
meiotic spindle. We have also observed that presence of
endogenous p39Mos in U0126-treated oocytes, which was
still able to phosphorylate MEK1, or injection of Mu-Mos
failed to rescue bipolar spindle formation in these condi-
tions, suggesting that p39Mos is not sufficient on its own toy activation by Mu-Mos, MEK, or Rsk injection. (A) Metaphase spindle as
y progesterone after overnight incubation. (B) Aster-shaped microtubular
against p39Mos synthesis and stimulated by progesterone after overnight
with 10 ng antisense oligonucleotides against p39Mos synthesis, incubated
sterone treatment. (D–F) Typical aster-shaped microtubular structure with
tides, incubated overnight and then injected with constitutively active Rsk
f the same figure as panel E. (G) Merge of panels E and F. (G–I) Typical
U0126, incubated 1 h and injected with constitutively active Rsk before
me figure as panel H. (J) Merging of panels H and I. (J) CA-Rsk but not
ng percentages of the different structure types observed in oocytes incubated
0126 and injected with either constitutively active Mos or Rsk. Error bars
ated. (K) Murine Mos but not CA-Rsk rescued bipolar axis establishment in
ure types observed in oocytes treated with p39Mos-sense Morpholino
9Mos-sense phosphorothioates oligonucleotides (PSS), or p39Mos-antisense
d constitutively active Rsk injection into oocytes treated either with p39Mos-
esterone. White bars show percentages of normal bipolar spindles, gray bars
centages of oocytes lacking any microtubular structures. Error bars represent
cated: N.S.: nonsignificant ( P > 0.05); *significant ( P < 0.05); **very
J.-F.L. Bodart et al. / Developmental Biology 283 (2005) 373–383382enable spindle organization. Injection of CA-Rsk was suffi-
cient to rescue the formation of a bipolar spindle at the
plasma membrane in U0126-treated oocytes (Table 2). This
supports a crucial role for p90Rsk in spindle morphogenesis,
through its activation by p39Mos–MEK1–Xp42Mpk1 cas-
cade. If injection of CA-Rsk was able to rescue spindle
morphogenesis in U0126-treated oocytes, it was not in
p39Mos-antisense-injected oocytes (Table 2). Failure of
spindle restoration in p39Mos-PSAS and CA-Rsk co-injected
oocytes, as well as in U0126-treated oocytes exhibiting
p39Mos levels sufficient to induce MEK1 phosphorylation,
suggests that p39Mos and p90Rsk are not sufficient on their
own to enable spindle organization. It also suggests that
both proteins are required together for spindle morphogen-
esis and that p39Mos may promote spindle organization
through separate pathways.
p39Mos has been demonstrated to associate and phos-
phorylate tubulin (Zhou et al., 1991). Kinetochores motor
protein CENP-E has been demonstrated to exhibit epitopes
that are modified upon a Mos-dependent manner in mouse
oocytes (Duesbery et al., 1997). Two-hybrid screening leads
to the identification of MISS, a MAPK Interacting and
Spindle Stabilizing protein. The latter accumulated only in
MII, where it was localized to the spindle (Lefebvre et al.,
2002). DOC1R has also been shown to be regulated by
phosphorylation during meiotic maturation by MAPK
pathway. DOC1R is localized to microtubules and injection
of DOC1R antisense RNA leads to microtubule defects in
MII oocytes (Terret et al., 2003). Recently, experiments
achieved by Gard and colleagues (Becker et al., 2003) have
provided new insights in the mechanisms of spindle
assembly and microtubule organization in Xenopus oocytes:
while NuMA and dynein are required for the organization of
TMA (Transient microtubule array) and MTOC, XMAP215
and kinesin-related XKCM1 have antagonistic roles in the
regulation of microtubule assembly and organization.
Nevertheless, further analyses are required to determine
how p39Mos and its downstream effectors could regulate the
molecular mechanisms of spindle morphogenesis. Because
we did observe aster-like structure similar to those observed
following progesterone stimulation in either XMAP215
antibodies or XKCM1 antibodies injected oocytes (Becker
et al., 2003), one might hypothesize that these molecules
could be targeted by the p39Mos–Xp42Mpk1 pathway.
Our work provides in ovo evidence that the p39Mos–
MEK1–Xp42Mpk1–p90Rsk cascade is required for correct
establishment of bipolar axis of the meiotic spindle in
Xenopus oocytes.Acknowledgments
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